ArticleApplied health economics and health policy2023

Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis.

Yawen Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.